Sign In | Administration | Contact us
Search

Westmead Millennium Institute for Medical Research Home Page

New building boosts medical research Prime Minister Tony Abbot and Premier of New South Wales, Mike Baird open the new WMI building

A state-of-the-art, $110 million, medical research centre has been officially opened in Western Sydney by the Prime Minister, Tony Abbott and Premier of New South Wales, Mike Baird.

The new Westmead Millennium Institute for Medical Research building brings together almost 400 clinicians, scientists, postgraduate students and support staff with the aim of accelerating research into Australia’s major health problems and translating its outcomes into new diagnostics, prognostics, preventions, therapies and cures. Click here for more information.

Contact UsLike us on Facebook Find us on YouTube

We are proudly affiliated with the University of Sydney.

A step closer to cure for AIDS

WMI researchers have helped complete the first successful clinical trial of a new drug that treats HIV when it lays dormant in human cells.
The drug panobinostat has been found to reactivate latently HIV-infected cells in patients currently on suppressive anti-HIV therapy, raising the hope of purging the virus from the body entirely.
Current drugs used to treat AIDS patients are not curative; they can reduce the expression of HIV in cells, but it still persists in the body. This is because the HIV virus can enter a dormant, or latent state, which also means patients can never go off treatment or the virus will re-emerge.
Click here for more information.

 

Depressed brains wired differently

Thanks to the use of a newly developed research framework called human brain connectomics, researchers from the Brain Dynamics Centre at Westmead Millennium Institute have discovered that the wiring in the brains of depressed patients is different than in non-depressed people, a finding that provides novel insights into the pathogenesis of depression and may lead to more targeted treatment plans for depression.  

Click here for more information.